Rheumatic Disease: Clinical Trials

2 trials for Rheumatic Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting, 1 unknown. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Recruiting 1, Unknown 1
Phase 11Unknown 1

Follow Rheumatic Disease: new trials by email Literature Review of Rheumatic Disease trials Research Report on Rheumatic Disease

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
Methotrexate, Sulfasalazine, Hydroxychloroquine - Rheumatic Disease
Phase 2RecruitingNYU Langone Health802025-12-122026-07-09
Intraarticular Opioids Vs Glucocorticosteroids in Gonarthritis
intraarticular morphine, intraarticular dexamethasone - Rheumatic Disease
Phase 1 / Phase 2UnknownCharite University, Berlin, Germany1202004-06-012006-09-11

Narrower conditions

Rheumatic Diseases (2)  ·  Arthritis, Juvenile (1)  ·  Arthritis, Psoriatic (1)  ·  Arthritis, Rheumatoid (1)  ·  Dermatomyositis (1)  ·  Giant Cell Arteritis (1)  ·  Granulomatosis with Polyangiitis (1)  ·  Lupus Erythematosus, Systemic (1)  ·  Polymyalgia Rheumatica (1)  ·  Polymyositis (1)  ·  Spondylarthritis (1)  ·  Spondylitis, Ankylosing (1)  ·  Vasculitis (1)

Broader conditions

Connective Tissue Diseases (2)  ·  Musculoskeletal Diseases (2)  ·  Skin and Connective Tissue Diseases (2)  ·  Ankylosis (1)  ·  Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1)  ·  Arteritis (1)  ·  Arthritis (1)  ·  Autoimmune Diseases (1)  ·  Autoimmune Diseases of the Nervous System (1)  ·  Axial Spondyloarthritis (1)  ·  Bone Diseases (1)  ·  Brain Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cerebrovascular Disorders (1)

Interventions

Abatacept (1)  ·  Adalimumab (1)  ·  Azathioprine (1)  ·  Certolizumab Pegol (1)  ·  Cyclosporine (1)  ·  Etanercept (1)  ·  Hydroxychloroquine (1)  ·  Infliximab (1)  ·  Interleukin 1 Receptor Antagonist Protein (1)  ·  Leflunomide (1)  ·  Methotrexate (1)  ·  Mycophenolic Acid (1)  ·  Rituximab (1)  ·  Sulfasalazine (1)  ·  Tacrolimus (1)

Sponsors

Charite University, Berlin, Germany (1)  ·  NYU Langone Health (1)

Countries

Germany (1)  ·  United States (1)

Top investigators

Joachim Sieper, Prof. (1)  ·  Jonathan Samuels, MD (1)